Willem J. de Lange

Willem J. de Lange

Auto-generated profile, based on publicly available information

Willem J. de Lange

Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2008 in Cell Metabolism
Verified
Journal Article
Closed access
CHCarmen M. Halabi
Carmen M. Halabi
ABAndreas M. Beyer
Andreas M. Beyer
WLWillem J. de Lange
Willem J. de Lange
HKHenry L. Keen
Henry L. Keen
GBGary L. Baumbach
Gary L. Baumbach
CSCurt D. Sigmund
Curt D. Sigmund

1 November 2010 in Cell Metabolism
Verified
Journal Article
Closed access
JGJustin L. Grobe
Justin L. Grobe
CGConnie L. Grobe
Connie L. Grobe
TBTerry G. Beltz
Terry G. Beltz
SWScott G. Westphal
Scott G. Westphal
DMDonald A. Morgan
Donald A. Morgan
CSCurt D. Sigmund
Curt D. Sigmund

1 April 2008 in Hypertension
Verified
Journal Article
Closed access
PDF file
ABAndreas M. Beyer
Andreas M. Beyer
GBGary L. Baumbach
Gary L. Baumbach
CHCarmen M. Halabi
Carmen M. Halabi
MMMary L. Modrick
Mary L. Modrick
CLCynthia M. Lynch
Cynthia M. Lynch
FFFrank M. Faraci
Frank M. Faraci
The transcription factor PPARγ is expressed in endothelium and vascular muscle where it may exert antiinflammatory and antioxidant effects. We tested the hypothesis that PPARγ plays a protective role in the vasculature by examining vascular structure and function in heterozygous knockin mice expressing the P465L dominant negative mutation in PPARγ (L/+). In L/+ aorta, responses to the endothelium-dependent agonist acetylcholine (ACh) were not affected, but there was an increase in contraction to serotonin, PGF 2α , and endothelin-1. In cerebral blood vessels both in vitro and in vivo, ACh produced dilation that was markedly impaired in L/+ mice. Superoxide levels were elevated in cerebral arterioles from L/+ mice and responses to ACh were restored to normal with a scavenger of superoxide. Diameter of maximally dilated cerebral arterioles was less, whereas wall thickness and cross-sectional area was greater in L/+ mice, indicating cerebral arterioles underwent hypertrophy and remodeling. Thus, interference with PPARγ signaling produces endothelial dysfunction via a mechanism involving oxidative stress and causes vascular hypertrophy and inward remodeling. These findings indicate that PPARγ has vascular effects which are particularly profound in the cerebral circulation and provide genetic evidence that PPARγ plays a critical role in protecting blood vessels.

1 October 2012 in Cell Metabolism
Verified
Journal Article
Closed access
CPChristopher J. Pelham
Christopher J. Pelham
PKPimonrat Ketsawatsomkron
Pimonrat Ketsawatsomkron
SGSéverine Groh
Séverine Groh
JGJustin L. Grobe
Justin L. Grobe
WLWillem J. de Lange
Willem J. de Lange
CSCurt D. Sigmund
Curt D. Sigmund

12 September 2008 in Circulation Research
Verified
Journal Article
Closed access
PDF file
ABAndreas M. Beyer
Andreas M. Beyer
WLWillem J. de Lange
Willem J. de Lange
CHCarmen Halabi
Carmen Halabi
MMMary L. Modrick
Mary L. Modrick
HKHenry L. Keen
Henry L. Keen
CSCurt D. Sigmund
Curt D. Sigmund
The ligand-activated transcription factor peroxisome proliferator activated receptor gamma (PPARγ) is expressed in vascular endothelium where it exerts anti-inflammatory and antioxidant effects. However, its role in regulating vascular function remains undefined. We examined endothelial function in transgenic mice expressing dominant-negative mutants of PPARγ under the control of an endothelial-specific promoter to test the hypothesis that endothelial PPARγ plays a protective role in the vasculature. Under baseline conditions, responses to the endothelium-dependent agonist acetylcholine were not affected in either aorta or the basilar artery in vitro. In response to feeding a high-fat diet for 12 weeks, acetylcholine produced dilation that was markedly impaired in the basilar artery of mice expressing dominant-negative mutants, but not in mice expressing wild-type PPARγ controlled by the same promoter. Unlike basilar artery, 12 weeks of a high-fat diet was not sufficient to cause endothelial dysfunction in the aorta of mice expressing dominant-negative PPARγ, although aortic dysfunction became evident after 25 weeks. The responses to acetylcholine in basilar artery were restored to normal after treatment with a scavenger of superoxide. Baseline blood pressure was only slightly elevated in the transgenic mice, but the pressor response to angiotensin II was augmented. Thus, interference with PPARγ in the endothelium produces endothelial dysfunction in the cerebral circulation through a mechanism involving oxidative stress. Consistent with its role as a fatty acid sensor, these findings provide genetic evidence that endothelial PPARγ plays a critical role in protecting blood vessels in response to a high-fat diet.

1 January 2015 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
KRKunil K. Raval
Kunil K. Raval
RTRan Tao
Ran Tao
BWBrent E. White
Brent E. White
WLWillem J. De Lange
Willem J. De Lange
CKChad H. Koonce
Chad H. Koonce
TKTimothy Kamp
Timothy Kamp
Infantile-onset Pompe disease is an autosomal recessive disorder caused by the complete loss of lysosomal glycogen-hydrolyzing enzyme acid α-glucosidase (GAA) activity, which results in lysosomal glycogen accumulation and prominent cardiac and skeletal muscle pathology. The mechanism by which loss of GAA activity causes cardiomyopathy is poorly understood. We reprogrammed fibroblasts from patients with infantile-onset Pompe disease to generate induced pluripotent stem (iPS) cells that were differentiated to cardiomyocytes (iPSC-CM). Pompe iPSC-CMs had undetectable GAA activity and pathognomonic glycogen-filled lysosomes. Nonetheless, Pompe and control iPSC-CMs exhibited comparable contractile properties in engineered cardiac tissue. Impaired autophagy has been implicated in Pompe skeletal muscle; however, control and Pompe iPSC-CMs had comparable clearance rates of LC3-II-detected autophagosomes. Unexpectedly, the lysosome-associated membrane proteins, LAMP1 and LAMP2, from Pompe iPSC-CMs demonstrated higher electrophoretic mobility compared with control iPSC-CMs. Brefeldin A induced disruption of the Golgi in control iPSC-CMs reproduced the higher mobility forms of the LAMPs, suggesting that Pompe iPSC-CMs produce LAMPs lacking appropriate glycosylation. Isoelectric focusing studies revealed that LAMP2 has a more alkaline pI in Pompe compared with control iPSC-CMs due largely to hyposialylation. MALDI-TOF-MS analysis of N-linked glycans demonstrated reduced diversity of multiantennary structures and the major presence of a trimannose complex glycan precursor in Pompe iPSC-CMs. These data suggest that Pompe cardiomyopathy has a glycan processing abnormality and thus shares features with hypertrophic cardiomyopathies observed in the congenital disorders of glycosylation. Background: How the absence of lysosomal enzyme acid α-glucosidase causes hypertrophic cardiomyopathy in Pompe disease is unknown. Results: Pompe patient-induced pluripotent stem cell-derived cardiomyocytes have normal autophagic and contractile function but exhibit a deficit of Golgi-based protein glycosylation. Conclusion: Loss of the lysosomal glycogen hydrolyzing ability results in protein glycosylation deficits. Significance: Malfunctioning proteins due to misglycosylation may contribute to the pathophysiology of Pompe cardiomyopathy.